PCCB17098 / APEC1621SC / Angela GirvinResearch Question:
How well does treatment that is directed by genetic testing work in pediatric patients
with solid tumors?
Basic Study Information
Purpose:Location: University of Rochester
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well
treatment that is directed by genetic testing works in pediatric patients with solid
tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following
at least one line of standard systemic therapy and/or for which no standard treatment
exists that has been shown to prolong survival. Genetic tests look at the unique genetic
material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities
(mutations) may benefit more from treatment which targets their tumor's particular
genetic mutation, and may help doctors plan better treatment for patients with solid
tumors or non-Hodgkin lymphomas.
Lead Researcher (Principal Investigator)
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search